Tuberculosis is the predominant cause for mortality from chronic pulmonary bacterial infections worldwide causing nearly two million deaths yearly. Tuberculosis has become more serious as a consequence of the global AIDS epidemic and the emergence of multidrug-resistant Mycobacterium tuberculosis ( Mtb ), the causative agent of tuberculosis ( 1 ) . Natural transmission of Mtb occurs predominantly via inhalation of aerosols containing small numbers of bacteria that are deposited in the distal airways of the lung ( 2 ) . The pathogens are phagocytosed by pulmonary M , which serve as a sanctuary for Mtb ( 3 ) . Virulent Mtb , which reside in M , initially evade elimination by the immune system via preventing apoptosis and inhibiting maturation of the phagosome -lysosome organelle of the host M ( 4, 5 ) . The net eff ect is to diminish entry of bacterial proteins into the class II MHC antigen-processing pathway ( 4 ) and to create a protected intracellular milieu where bacilli remain metabolically active and replication competent ( 6 ) . For M infected with virulent H37Rv, necrosis characterized by cytolysis is the dominant form of cell death, which aff ords a protective milieu for Mtb ( 7, 8 ) . Thus, subversion of cell death toward necrosis is of considerable advantage for the pathogen. acid (AA) from the sn-2 position of membrane phospholipids ( 28 ) . AA and its functionally diverse and biologically active eicosanoid products have been implicated in the regulation of programmed cell death in several cell types ( 29, 30 ) . The lipoxins are AA metabolites generated by 5-and 15-lipoxygenases (5-and 15-LO) ( 31 ) . Lipoxins modulate chemokine and cytokine expression, stimulate monocyte traffi cking, and enhance M engulfment of apoptotic leucocytes ( 32 ) . However the role of 5-LO products of AA such as lipoxins and leukotriene B 4 , which amplifi es PMN chemotaxis and production of granule products ( 33 ) , has not been elucidated in modulating the death modality of M .
Prostanoids are lipid mediators generated from AA by the enzymatic action of the cyclooxygenases (COX) 1 and 2 to form the intermediate PGH 2 , with subsequent metabolism to specifi c prostanoid species (e.g., PGD 2 , PGE 2 , PGF 2 ␣ , PGI 2 , and thromboxane) by prostaglandin synthases ( 34, 35 ) . The functions of these prostanoids are defi ned by an array of specifi c receptors. In the case of PGE 2 , diff erential expression of four distinct EP receptors defi nes the intracellular pathways that are activated by PGE 2 and results in specifi c functions that might either promote or inhibit infl ammation. For example, in the lung, PGE 2 either promotes vasodilatation and increases vascular permeability or increases bronchodilatation ( 36 ) . A recent study describes a noninfl ammatory function of PGE 2 , up-or down-regulation of programmed cell death, which indicates that the mechanisms of PGE 2 activation are complex and context dependent ( 37 ) .
Mice with a deleted 5-LO gene have increased IL-12, IFN-␥ , and NO synthase 2 levels compared with WT mice after pulmonary Mtb infection. 5-LO Ϫ / Ϫ mice also have signifi cantly lower Mtb burdens and survive longer than WT animals after respiratory Mtb infection ( 38 ) . Importantly, administration of a stable LXA 4 analogue was suffi cient to reverse the increased resistance of 5-LO Ϫ / Ϫ mice to Mtb infection. The fi nding that Mtb infection signifi cantly increases AA production via activation of cPLA 2 -␥ ( 27 ) and that 5 LO Ϫ / Ϫ mice are signifi cantly more resistant to Mtb infections ( 38 ) , raised the question of whether eicosanoid production is involved in macrophage necrosis and inhibition of apoptosis induced by virulent Mtb . We hypothesize that stimulation of lipoxin by virulent Mtb inhibits macrophage apoptosis, promotes necrosis, and represents a mechanism that allows Mtb to evade elimination by the innate immune system. We therefore investigated how lipoxins and prostanoids aff ect the outcome of Mtb -driven M death with respect to apoptosis and necrosis as a novel pathogenic mechanism that regulates the innate immune response in Mtb infection.
RESULTS

Virulent Mtb trigger production of LXA 4 in M
We demonstrated that inhibition of cPLA 2 abrogates apoptosis in Mtb -infected M , which could be restored by reconstitution of AA, the predominant product of cPLA 2 ( 27 ) . These fi ndings suggest that products synthesized from AA, namely the eicosanoids, regulate programmed M death induced A common mechanism of necrosis is induction of mitochondrial permeability transition (MPT), which is manifested as accelerated cell death with plasma membrane disintegration. It is thought that a pore opens in the inner mitochondrial membrane allowing water and other molecules to pass through. Opening of this permeability transition pore can be triggered by multiple stimuli and leads to dissipation of the mitochondrial inner membrane potential ( ⌬ ⌿ m ) ( 9 ) . Irreversible induction of MPT leads to mitochondrial damage associated with mitochondrial swelling and subsequent necrosis of the cell. In vitro M infected with virulent H37Rv causes the catastrophic irreversible MPT that commits the M to necrosis ( 10 ) .
The active nature of this necrosis induction by virulent Mtb is clearly revealed after infection of M with mutants of Mtb . Although host M support growth of virulent Mtb ( 3 ), innate immune mechanisms are activated that limit pathogen survival after infection with Mtb mutants having altered virulence. These responses include induction of apoptosis, a slow cell death modality which leaves the plasma membrane intact and is observed after infection of M with attenuated Mtb ( 11 -13 ) . This M death modality limits exploitation of the intracellular growth environment through direct microbicidal eff ects and by sequestering bacilli in apoptotic bodies. Indeed, apoptosis both enhances antigen presentation by DC ( 14 ) and facilitates effi cient pathogen killing ( 15 -18 ) .
Two pathways are described that lead to this highly regulated form of cell death ( 19 ) . First, the extrinsic apoptotic pathway implicates binding of the ligands TNF and FasL to their receptors that trigger apoptosis ( 20 ) . Second, the intrinsic apoptotic pathway involves the mitochondria, which release cytochrome c and other factors from the mitochondrial intermembrane space that promote apoptosis ( 21, 22 ) .
We demonstrated previously that mitochondria play an essential role to determine whether Mtb -infected M undergo cytolytic necrosis or apoptosis ( 8 ) . Apoptosis induced by the mitochondrial pathway commences with Ca 2+ release from the ER that leads to an increase of Ca 2+ in the mitochondria as well as translocation of BAX into the mitochondria and BAK activation ( 23 ) . Permeabilization of the mitochondrial outer membrane then proceeds via formation of a proteolipid pore and subsequent escape of proteins from the mitochondrial intermembrane space into the cytosol. More specifi cally, upon mitochondrial outer membrane permeabilization proapoptotic factors, including cytochrome c , are released from the mitochondrial intermembrane space into the cytosol. There, cytochrome c forms a complex with Apaf-1, leading to activation of caspase-9 that, in turn, activates executioner caspases such as caspase-3, -6, and -7, which are instrumental in the induction of apoptosis ( 19, 24 ) .
Infection with the attenuated Mtb H37Ra, which has a mutation in PhoP which inhibits ESX-1 function ( 25 ), predominantly prevents necrosis and leads to sequestration and decimation of the intracellular bacteria ( 8, 26 ) .
Mtb -induced apoptosis and antimycobacterial activity of human M requires the activity of cPLA 2 -␥ , a group IV cytosolic PLA 2 (cPLA 2 ) ( 27 ) which catalyzes the release of arachidonic The production of LXA 4 was measured over time in supernatants from M infected with virulent and avirulent Mtb . Virulent H37Rv induce signifi cantly higher levels of LXA 4 production (1 nM; Fig. 1 B ) . Similar results are observed with another virulent strain (Erdmann strain [not depicted]). In contrast, when M are infected with avirulent H37Ra, production of LXA 4 reaches ‫ف‬ 0.4 nM at 4 and 6 h after infection but is then subsequently down-regulated to ‫ف‬ 0.2 nM at 12 h. The amount of LXA 4 production induced by H37Rv correlates with the multiplicity of infection (MOI; Fig. 1 C ) . In contrast, the amount of LXA 4 production after H37Ra infection was not increased when the MOI was raised.
These fi ndings raised the question of whether M infected with virulent Mtb negatively regulate COX2 expression. Infection of M with the virulent H37Rv induced little accumulation of COX2 mRNA and COX2 protein compared with infection with the mutant Mtb strain H37Ra, suggesting that H37Rv infection inhibits COX2 expression ( Fig. 1, D and E ). These fi ndings suggest that infection with virulent Mtb induces the production of LXA 4 in suffi cient quantities to inhibit COX2 production, which represents an important manifestation of bacterial virulence.
The virulent Mtb strain H37Rv inhibits prostanoid production by the host M COX2, the inducible PGH synthase, is required for prostanoid synthesis ( 40 ) . To study whether inhibition of COX2 expression by H37Rv had any functional consequences, we measured prostanoid production by Mtb -infected M . PGE 2 levels of < 1 nM were detected in supernatants of H37Rv-infected M during the fi rst 48 h of infection. In contrast, levels of PGE 2 were produced by M infected with H37Ra, which increased over time and could be correlated with the MOI ( Fig. 2, A and B ) . Infection with H37Ra also signifi cantly induced production of the prostanoids PGF 2 ␣ ( Fig. 2 C ) and TXA 2 (not depicted). In contrast, the virulent Mtb strain H37Rv failed to induce signifi cant prostanoid production ( Fig. 2, A -C ) . To determine whether these fi ndings were not confounded by altered bacterial uptake, survival, or replication, we measured bacterial counts. 72 h after infection, the bacterial burden was similar between M infected with H37Rv and H37Ra (unpublished data).
Thus, virulent Mtb suppress COX2 expression in infected M , which leads to a global inhibition of prostanoid production. Although prostanoid synthesis is signifi cantly inhibited by H37Rv, the amount that is produced is likely to be an important counterbalance to LXA 4 because M exposed to 1 nM LXA 4 are highly sensitive to PGE 2 and respond to ‫ف‬ 1 -2 logs lower PGE 2 concentrations than M not exposed to LXA 4 with a protective response against necrosis (Fig. S1 , available at http://www.jem.org/cgi/content/full/jem.20080767/DC1). PGE 2 suppresses mitochondrial inner membrane perturbation (MPT) and necrosis in M infected with virulent Mtb Virulent H37Rv induce rampant necrosis. In contrast, avirulent H37Ra fail to induce M necrosis ( 7, 8, 12 ) . The observation by Mtb . Two groups of eicosanoids are of special interest because of their opposing eff ects, the prostanoids that are derived by the COX pathway ( 34 ) and the lipoxins, a distinct class of LO-derived products which promote termination of infl ammation ( 39 ) .
The identifi cation of PGE 2 and LXA 4 in infected M supernatants was established from the diagnostic ions present in their liquid chromatography tandem mass spectrometry (LC-MS-MS) spectra ( Fig. 1 A ) . We extended these studies by performing ELISA assays on H37Rv-and H37Ra-infected M . cated in experiments with mouse M (unpublished data). Addition of exogenous PGE 2 also inhibited necrosis measured by 7-AAD staining of H37Rv-infected M . Specifi cally, addition of 1 μ M PGE 2 to H37Rv-infected M decreased the number of 7-AAD -positive M after 48 h from 29 ± 1 to 17 ± 1% after infection with H37Rv (background 2.2 ± 0.5%; MOI 10:1; P < 0.01; n = 3). Other prostanoids, such as PGD 2 , PGF 2 ␣ , PGI 2 , and TXA 2 , and leukotriene LTB 4 , had little or no eff ect on prevention of necrosis ( Fig. 3 C ) .
We next confi rmed the role of PGE 2 in protection against Mtb infection-induced necrosis using a loss-of-function approach. In this study, we reasoned that Mtb -induced PGE 2 production is a default pathway for the innate immune response, which may be interrupted in H37Rv infection. Thus, infection that infection of M with H37Rv induces LXA 4 and inhibits COX2 and prostanoid production, whereas H37Ra infection fails to induce LXA 4 but stimulates COX2 and prostanoid production, led to the hypothesis that H37Rv-induced LXA 4 production may foster M necrosis via inhibition of PGE 2 production. Conversely, H37Ra infection may stimulate PGE 2 -mediated inhibition of LXA 4 and prevent M necrosis. By determining the release of the cationic dye DiCO 6 (3) from mitochondria, a correlate of M necrosis ( 41 ), we fi rst investigated whether prostanoids block induction of H37Rv-induced necrosis. Indeed, increasing micromolar concentrations of PGE 2 signifi cantly decreased cationic dye release from the mitochondria of human M infected with virulent H37Rv (MOI 10) after 24 h ( Fig. 3 , A -C ). These results were dupli- analogue added to H37Ra-infected M dramatically inhibited both COX2 protein and PGE 2 production induced by H37Ra ( Fig. 4 B ) . Silencing of the 5-LO gene ( Fig. 4 C , left) in M infected with the virulent H37Rv inhibited H37Rv-induced LXA 4 production ( Fig. 4 C , right) and reduced necrosis ( Fig. 4 D ) , demonstrating that 5-LO activity is required for LXA 4 production by H37Rv-infected M . Finally, inhibition of LXA 4 synthesis in H37Rv-infected M by 5-LO gene silencing led to PGE 2 production ( Fig. 4 E ) . These results not only provide additional proof that LXA 4 suppresses PGE 2 production but demonstrate that the induction of of microsomal prostaglandin E synthase (mPGES) Ϫ / Ϫ M defi cient of PGE 2 production with H37Ra should mimic the virulent status in H37Rv infection and stimulate necrosis. As anticipated, PGES Ϫ / Ϫ M ( 42 ) are unable to produce PGE 2 after infection with avirulent H37Ra and show a concomitant phenotypic switch to susceptibility to necrosis after infection ( Fig. 3 D ) . These results demonstrate that PGES activity inhibits Mtb -induced necrosis. Addition of exogenous PGE 2 to H37Ra-infected PGES Ϫ / Ϫ M restored the avirulent phenotype with striking inhibition of necrosis and confi rms that PGE 2 is a central mediator in cell death regulation of Mtb -infected M ( Fig. 3 D ) .
To ascertain that induction of human and mouse M necrosis by Mtb is caused by related mechanisms, we determined the amount of necrosis after infection with the same MOIs of H37Ra or H37Rv. The results show that both human and mouse M have a similar necrosis response after infection (Fig. S2 , available at http://www.jem.org/cgi/content/full/jem.20080767/DC1).
Defi ning the existence of distinct mechanisms that regulate necrosis and apoptosis, and having observed a PGE 2 -dependent modulation in the context of Mtb infection, we next investigated whether PGE 2 has a direct role in the regulation of M apoptosis. In this study, we assessed PGE 2 -stimulated cytochrome c release from the mitochondrial intermembrane space ( 19 ) , a correlate of apoptosis. Interestingly, we fi nd that PGE 2 does not modulate cytochrome c release in H37Ra or H37Rv-infected M ( Fig. 3 E ) , nor does it cause cytochrome c release in absence of infection (not depicted). Thus, PGE 2 plays no role in the induction of apoptosis.
Necrosis is positively regulated by LXA 4 through inhibition of prostanoid synthesis leading to mitochondrial inner membrane perturbation In the mouse model of Mtb infection, LXA 4 production correlates with reduced resistance against Mtb ( 38 ) . Our data reveal a relationship between LXA 4 production and M necrosis after virulent Mtb infection in vitro. These observations collectively suggest a functional contribution for LXA 4 in the induction of necrosis. We reasoned that if LXA 4 production is a mechanism by which virulent H37Rv promote necrosis in infected M , addition of LXA 4 to M infected with nonvirulent H37Ra should confer a virulent phenotype with regard to Mtb -induced necrosis. Indeed, LXA 4 signifi cantly enhanced cationic dye release from the mitochondria, a correlate of necrosis, in H37Ra-infected M ( Fig. 4 A , left) . Importantly, LXA 4 administration in the absence of Mtb infection has no eff ect on M necrosis ( Fig. 4 A , left) . Moreover, addition of LXA 4 to H37Ra-infected PGES Ϫ / Ϫ M , which are unable to synthesize PGE 2 , does not increase cationic dye release from the mitochondria ( Fig. 4 A , right) . These results suggest that in Mtb -infected M , LXA 4 acts by down-regulating PGE 2 synthesis to induce necrosis.
To investigate whether induction of necrosis by LXA 4 is based on an inhibitory eff ect of LXA 4 on PGE 2 synthesis, we determined whether LXA 4 blocks synthesis of COX2, thus inhibiting generation of PGE 2 . Indeed, 10 Ϫ 9 M of stable LXA 4 
Pulmonary Mtb infection in mice is controlled by PGE 2
The fi ndings presented in the previous section indicate that infection with virulent Mtb leads to the induction of LXA 4 and suppression of PGE 2 , which results in the necrotic death of infected M . We therefore performed in vitro experiments with M from WT and PGES Ϫ / Ϫ mice. Fig. 6 A shows that after 4 d of H37Rv infection, the bacterial growth was comparable between WT and PGES Ϫ / Ϫ M . However, 7 d after infection the bacterial burden was signifi cantly higher in PGES Ϫ / Ϫ M than in WT M . These data suggested that PGE 2 plays a major regulatory role in controlling bacterial growth in M and predicted that an alteration in the balance between PGE 2 and LXA 4 might change the in vivo outcome of infection. Indeed, 5-LO Ϫ / Ϫ mice are more LXA 4 by Mtb is a potential mechanism that prevents PGE 2 production and leads to cell necrosis.
The prostanoid receptor EP2 is involved in protection of the mitochondrial inner membrane of Mtb -infected M by PGE 2 The action of PGE 2 on the M is mediated by four distinct G protein -coupled E prostanoid (EP) receptors, referred to as EP1, EP2, EP3, and EP4 ( 43 ) , and mice defi cient in the four PGE 2 receptors have been generated ( 44 -47 ) . All four receptors are expressed by human M ( Fig. 5 A ) . The EP1 receptor is functionally connected to Gq, a G protein that increases Ca 2+ i . The EP2 and EP4 receptors activate G proteins that activate adenylate cyclase leading to increased cAMP production. The EP3 receptor inhibits adenylate cyclase via Gi and reduces cAMP levels. To confi rm the central role of PGE 2 and to more precisely determine its action via specifi c EP receptors in protection of the mitochondrial inner membrane from MPT, we determined the eff ect of exogenous PGE 2 on cationic dye release in WT M and M from homozygote EP1, EP2, EP3, and EP4 Ϫ / Ϫ mice infected with H37Ra and H37Rv. M from WT, EP1, EP3, and EP4 Ϫ / Ϫ mice responded to increasing exogenous PGE 2 concentrations with enhanced inhibition of cationic dye release induced by H37Rv. Cationic dye release from the mitochondria in EP2 Ϫ / Ϫ M infected with H37Rv could not be inhibited even by high concentrations of PGE 2 , indicating that EP2 is the major PGE 2 receptor responsible for inhibition of mitochondrial cationic dye release. Identical results were obtained when the cells were infected with H37Ra ( Fig. 5 B ) .
Stimulation of EP2 and EP4 receptors triggers activation of adenylate cyclase ( 48 ) . EP2 is associated with activation of protein kinase A (PKA) ( 49 -51 ) . In contrast, signaling through EP4 mainly stimulates phosphatidylinositol-3 kinase (PI3K) -mediated processes ( 49, 52 ) . To confi rm that the inhibition of mitochondrial cationic dye release is modulated by stimulation of EP2, we examined the eff ect of the specifi c PKA inhibitor KT5720 ( 53 ) on PGE 2 -dependent inhibition of mitochondrial cationic dye release. We also confi rmed lack of involvement of the EP4-stimulated PI3K pathway by testing the eff ect of the PI3K inhibitor LY294002 on mitochondrial cationic dye release ( 54 ) . KT5720, at concentrations previously shown to protect cells from apoptosis (10 Ϫ 7 M [reference 53 ]), abrogated the protective effect of PGE 2 on M ( Fig. 5 C ) . In agreement with the postulated hypothesis that H37Ra is unable to induce necrosis in infected M because of induction of PGE 2 production, addition of KT5720 to H37Ra-infected M signifi cantly augmented M necrosis ( Fig. 5 C ) . In contrast, LY294002 had no eff ect ( Fig. 5 D ) . KT5720 and LY294002 alone had no eff ect on mitochondrial cationic dye release induced by H37Rv. These results are consistent with a mechanism wherein EP2 activation of PKA, rather than EP4 activation of PI3K, mediates the protective eff ect of PGE 2 on mitochondria of Mtbinfected M . M from EP1, EP3, and EP4 Ϫ / Ϫ mice were equally responsive to 1 μ M PGE 2 (*, statistically signifi cant; P < 0.01; n = 5). (C) The cAMP-dependent PKA inhibitor KT5720 abrogates inhibition of mitochondrial cationic dye release by PGE 2 (black columns; P < 0.01; n = 3). Addition of KT5720 to H37Ra-infected (MOI 10:1) M enhanced M necrosis (gray columns; *, P < 0.01; n = 3). (D) The PI3K inhibitor LY294002 does not abrogate inhibition of mitochondrial cationic dye release by PGE 2 (not signifi cant; n = 3). In all studies, n represents the number of independent experiments.
Our results demonstrate hitherto unappreciated disparate roles for LXA 4 and PGE 2 in the regulation of induction of host M necrosis, a cell death leading to cytolysis. M infected with virulent Mtb that produce LXA 4 and reduced amounts of PGE 2 undergo necrosis. In contrast, prevention of necrosis and concomitant induction of M apoptosis is associated with increased PGE 2 production. Thus, the induction of LXA 4 and the resulting inhibition of PGE 2 production contribute to the virulence of Mtb and enhance its capacity to evade killing by the innate immune system. Indeed, the failure of PGES Ϫ / Ϫ M to control H37Rv replication in vitro and the observation that PGES Ϫ / Ϫ mice have a 10-fold higher Mtb burden in their lungs compared with WT mice demonstrate the protective effect of PGE 2 against virulent Mtb . Preferential synthesis of either LXA 4 or of prostanoids is a critical branch point for the innate antimycobacterial response of the infected M ( Fig. 7 ) .
Lipoxins are best described as potent negative regulators of acute infl ammatory processes ( 55 ) , in part via inhibition of DC mobilization, inhibition of IL12 production ( 56 ) , and PMNinduced infl ammation in vivo. LXA 4 activities are multifold and include inhibition of PMN entry to sites of infl ammation, reduction of vascular permeability, promotion of monocyte infi ltration, and ingestion of apoptotic cells, perhaps including infected M by phagocytes ( 39 ) . Moreover, lipid mediators that resolve infl ammatory events, including LXA 4 , stimulate phagocytosis of zymosan and of microbial organisms leading to de novo infection of phagocytes ( 56 ) . The results suggest that the action of LXA 4 in reducing prostanoid production as part of the infl ammation-resolving program of LXA 4 is exploited by Mtb in the local environment. Thus, although temporally regulated dampening of the infl ammatory response is generally highly benefi cial to the host, our studies uncover a novel scenario wherein LXA 4 -driven reduction of " proinfl ammatory " PGE 2 synthesis functionally acts as an effi cient mechanism used by pathogenic Mtb . More specifi cally, LXA 4 counteracts the resistant to infection ( 38 ) . Similarly, we would predict that in the absence of PGES, mice are more susceptible to infection. WT and PGES Ϫ / Ϫ mice were infected by the aerosol route with 100 virulent Mtb per lung. Similar numbers of bacteria were found in the lungs of both WT and PGES Ϫ / Ϫ mice on day 1 after infection ( n = 4/group). The bacterial burden in WT and PGES Ϫ / Ϫ mice was not diff erent 2 wk after infection (unpublished data). However, after 5 wk WT mice controlled the infection more effi ciently compared with the PGES Ϫ / Ϫ mice, whose lungs contained more bacteria ( ⌬ log 10 = 0.97; P = 0.0079; Fig. 6 ). This diff erence was not observed in the spleen (unpublished data). To assess whether the balance between PGE 2 and LXA 4 is changed during the course of a mycobacterial infection in vivo, we next measured the levels of PGE 2 and LXA 4 in sera from WT mice infected with either virulent Erdmann strain or avirulent H37Ra. As it was observed in vitro, virulent bacteria induced remarkably more LXA 4 after 7 d of infection, whereas avirulent H37Ra induced more PGE 2 . This indicates that PGE 2 signifi cantly contributes in vivo to protective responses against mycobacterial infection in the lung.
DISCUSSION
The central fi nding of this study is that in the local environment of an Mtb infection, M infected with virulent Mtb preferentially synthesize LXA 4 and little, if any, PGE 2 . In contrast, M infected with avirulent H37Ra produce mainly prostanoids, including PGE 2 , and only small amounts of LXA 4 . In contrast, M infected with avirulent H37Ra produce larger amounts of PGE 2 which blocks LXA 4 production and supports M apoptosis and containment of the Mtb. Predominant production of either PGE 2 or LXA 4 by M infected with H37Ra or H37Rv, respectively, is supported by the fact that PGE 2 inhibits LXA 4 production and vice versa.
is the predominant death modality of the host M infected with attenuated Mtb including H37Ra and secA2 mutants ( 13 ) . Apoptotic bodies are thought to provide a containment vessel for the bacilli as well as an effi cient means for pathogen killing ( 15 ) . Moreover, apoptotic bodies express specifi c cell surface receptors ( 61 ) that promote uptake and subsequent antigen presentation to DC ( 14 ) . Virulent Mtb subvert apoptosis and induce plasma membrane lysis (necrosis), leading to dissipation of the pathogens and spread of the infection.
Thus, the fate of the infected M with regard to cell death modality is a critical determinant in an eff ective host defense response to Mtb infection. Our studies identify a novel mechanism wherein Mtb stimulates a pathway involved in the local resolution of infl ammation to subvert defense mechanisms against Mtb . To our knowledge, this is the fi rst example of a pathway important in the resolution of infl ammation that is targeted by a pathogen to counteract the innate immune system. Although it is tempting to advocate therapeutic targets of the lipoxin pathway for Mtb infection, further studies are required both to understand the mechanisms by which LXA 4 production is activated via virulent Mtb and to determine the consequences of blocking the LXA 4 production in the course of an infection of M with Mtb for the host.
MATERIALS AND METHODS
Materials. LY294002, KT5720
, and propidium iodide (PI) were obtained from Sigma-Aldrich. DiOC 6 (3) (3,3 Ј -dihexyloxycarbocyanine iodide), rhodamine-2 AM, goat anti -mouse IgG 1 , and anti -mouse COX1 antibodies were obtained from Invitrogen. PGE 2 , PGF 2 ␣ , PGD 2 , PGI 2 , LTB 4 , TXB 2 , and LXA 4 , sheep anti -15-LO antibody, and mouse anti-COX2 antibody were obtained from Cayman Chemical. 15-epi-16-phenoxy-parafl uoro-LXA 4 -methyl ester was a gift from Bayer-Schering Pharma AG. Anti -␤ -actin mAb was obtained from Thermo Fisher Scientifi c. Mouse anti -5-LO antibody, mouse IgG 1 , and mouse anti -cytochrome c mAb (7H8.2C12.6H2.B4) were obtained from BD. IMDM, RPMI-1640, Opti-MEM I reduced serum medium, Oligofectamine, Hepes, and DTT were obtained from Invitrogen. Rabbit antiannexin-1 polyclonal antibody, goat anti -rabbit IgG FITC conjugate, and HRP protein A were obtained from Invitrogen. Anti -phosphatidyl-serine mouse mAb (clone1H6) and rabbit IgG were obtained from Millipore.
Mice. 6 -10-wk-old C57BL/6 mice were obtained from Jackson ImmunoResearch Laboratories. mPGES-1 Ϫ / Ϫ mice (N5 backcross onto the C57BL/6 background, 45) and EP1 (Ep1 Ϫ / Ϫ ; reference 47 ), EP2 Ϫ / Ϫ ( 48 ), EP3 Ϫ / Ϫ ( 47 ), and EP4 Ϫ / Ϫ mice ( 51 ) ( n > 10 on C57BL/6 background, provided by B. Koller, University of North Carolina, Chapel Hill, NC) were bred locally. All procedures were approved by the Dana-Farber Cancer Institute Institutional Animal Care and Use Committee.
Bacteria. The virulent Mtb strain H37Rv and the attenuated H37Ra (American Type Culture Collection), prepared as described previously ( 8 ) , were used in the in vitro experiments. The strains were grown in Middlebrook 7H9 broth (BD) with BBL Middlebrook OADC Enrichment (BD) and 0.05% Tween 80 (BD) and resuspended in 7H9 broth at 5 × 10 7 CFU/ml. Aggregation was prevented by sonication for 10 s. The bacteria were allowed to settle for 10 min. Bacteria in M were quantifi ed by lysis of the cells with 0.2% SDS in PBS. After neutralization of SDS with 50% FCS, 100 μ l of cell lysates of triplicate cultures were serially diluted 10-fold, plated on 7H10 agar plates (Remel), and colonies were counted after 21 d. Alternatively, the pooled cell lysates were inoculated into triplicate Bactec 12B vials. The number of bacteria was determined with the Bactec model 460 TB system (BD).
protective eff ects of PGE 2 by inhibiting COX2 expression, thereby causing necrosis in Mtb -infected M . Interestingly, LXA 4 on its own does not induce necrosis, indicating that the main function of LXA 4 is down-regulation of prostanoid production followed by mitochondrial inner membrane destabilization. These results are consistent with studies demonstrating that mycobacterial burden is signifi cantly reduced in 5-LO Ϫ / Ϫ mice in comparison to WT mice ( 38 ) and suggest that LXA 4 negatively regulates antimycobacterial defense responses. It should be noted that the concentrations of LXA 4 produced are not suffi cient to aff ect infl ammatory events in other experimental systems, a feature which is almost certain to be benefi cial to the Mtb pathogen. Consequently, Mtb is able to escape from the necrotic M without adverse eff ects and is able to infect newly recruited M .
The fi ndings in this paper argue that inhibition of PGE 2 comprises a mechanism specifi c for virulent Mtb , a distinctly noninfl ammatory role for this prostanoid in the regulated response to this pathogen. Prostanoids, including PGE 2 , are the fi nal product of the PGH synthases COX1 and 2. PGE 2 has been extensively studied and is well known for its role in mediating cardinal features of infl ammation, including pain, vasodilatation essential for the control of blood fl ow, and leukocyte diapedesis leading to edema and fever ( 34 ) . We now show that the prostanoid PGE 2 protects against MPT and necrosis of M infected with virulent Mtb . Our data are consistent with recently published fi ndings in several other experimental systems that document an inhibitory role of PGE 2 in cell death. This mechanism is clearly complex and can be mediated in those studies either by the EP2 receptor ( 57, 58 ) or the EP4 receptor ( 59 ). Although we defi nitively confi rm the role of PGE 2 and more precisely defi ne its mechanistic activity by identifying EP2 as the crucial PGE 2 receptor, these fi ndings beg for further dissection of this important signaling pathway leading to increased M defense against Mtb.
The mechanisms by which PGE 2 stimulates induction of apoptosis of Mtb -infected M is not understood. Although PGE 2 stimulation of the EP4 receptor triggers activation of PI3K and of Akt ( 48 ) , blockade of mitochondrial damage by PGE 2 critical for prevention of necrosis is mediated through the EP2 receptor. The EP2 subtype couples to G protein ␣ s and triggers intracellular cAMP formation. cAMP activates the PKA pathway ( 45 ) , which inhibits death in several cell types ( 58 ) . PKA activation was found to block cell death by phosphorylation of the proapoptotic protein Bad ( 49, 50, 54 ) , causing its inactivation, and also increases the expression of Bcl-2 involving the CREB (cAMP responsive element-binding) protein and inhibition of cell death ( 59 ) . At present, we do not know which of these mechanisms is involved in the mitochondrial inner membrane stabilization by PGE 2 and in the inhibition of LXA 4 production.
The innate immune system is the fi rst line of defense against invading microbial pathogens and viruses ( 60 ) . Apoptosis characterized by intact plasma membranes, formation of apoptotic bodies and DNA fragmentation is an important component of the innate immune defense against Mtb and TTCAAATGAGATTGTGGGAAAATTGCT and AGATCATCTCTG-CCTGAGTATCTT. Primer sequences for GAPDH were ACCACAG-TCCATGCCATCAC and TCCACCACCCTGTTGCTGTA. PI staining. Adherent mPGES Ϫ / Ϫ spleen M adherent were stained with 2.5 μ g/ml PI in RPMI containing 10% FBS at 4 ° C for 10 min and washed with ice-cold PBS and H 2 O. Dried and mounted coverslips were examined using a fl uorescence microscope and photographed with a digital camera (DFC300; Leica). siRNA transfection. The 5-LO siRNA target sequence (AAATGCCA-CAAGGATTTACCC) targeted against NM_000698 and a scrambled control siRNA sequence (GCCCTCTATCGAATAAGACAA) designed with siRNA target fi nder (Ambion) ( 63 ) was used. The siRNAs were synthesized from DNA templates with the Silencer siRNA construction kit (Ambion) according to the manufacturer ' s instructions. Cells were cultured in IMDM with 10% human AB serum, and the medium was changed 1 d before transfection. All siRNAs were used at a fi nal concentration of 50 nM by diluting with Opti-MEM I reduced serum medium. To oligofectamine (1:200 dilution; Invitrogen), fresh IMDM containing 30% human AB serum (Gemini Bio-Products) was added to bring the serum concentration to 10%. After 72 h of transfection at 37 ° C, the cells were infected with Mtb . To examine the eff ect of siRNA transfection, cells were harvested and analyzed using Northern or Western blotting.
Statistics.
Results are expressed as mean ± SEM. The data were analyzed by using Excel Statistical Software (Microsoft) using the Student ' s t test for normally distributed data with equal variances. CFU were log 10 transformed and analyzed using the Mann Whitney nonparametric t test. A p-value < 0.05 was considered statistically signifi cant.
Online supplemental material. Fig. S1 shows sensitization of human M with 1 nM LXA 4 , 1 h before infection with H37Ra (MOI 10:1) to decreasing concentrations of PGE 2 . Fig. S2 shows FACS analysis of necrotic cells Aerosol infection of mice. C57BL/6 and mPGES-1 Ϫ / Ϫ mice were infected with virulent Mtb (Erdman strain) via the aerosol route using a noseonly exposure unit (Intox Products) and received ‫ف‬ 100 CFU/mouse ( 3, 15, 16 ) . After 5 wk, mice were killed by CO 2 inhalation and the left lung was aseptically removed and individually homogenized in 0.9% NaCl-0.02% Tween 80 with a Mini-Bead Beater 8 (BioSpec Products, Inc.). Viable bacteria were enumerated by plating 10-fold serial dilutions of organ homogenates onto 7H11 agar plates (Remel). Colonies were counted after 3 wk of incubation at 37 ° C.
LC-MS-MS and ELISA. PGE 2 , PGF 2 ␣ , PGD 2 , and LXA 4 concentrations in cell supernatants were determined using ELISA kits (Oxford Biomedical Research) according to the recommendations of the manufacturer. The TXA 2 concentration was determined with the TXB 2 express EIA kit (Cayman Chemical). 50 μ l of culture media from infected M was added to wells in duplicate and absorbance was determined using a microplate reader. The lipid concentration was determined using standard curves. LXA 4 and PGE 2 identity were confi rmed using LC-MS-MS diagnostic ions and their physical properties. For LC-MS-MS, an LCQ ion trap mass spectrometer (Finnigan Corp.) with an electrospray ionization probe was used ( 62 ) .
Assessment of MPT in M .
MPT was assessed in M by measuring retention of the cationic dye DiOC 6 (3) within the mitochondria ( 41 ). Cells were loaded with 3 nM DiOC 6 (3) in IMDM for 20 min at 37 ° C. After washing, 20 μ g digitonin was added per milliliter and the M were incubated at 37 ° C for 20 min and fi xed with 4% paraformaldehyde for 20 min at room temperature. Cells were dislodged with a rubber policeman, washed with PBS, and resuspended in PBS with 1% BSA. Flow cytometry was performed under FL-1 conditions using a BD FACSort fl ow cytometer (BD).
Western blotting. After incubation with Mtb (MOI 10:1), cells were harvested and lysed with SDS sample buff er (62.5 mM Tris-HCl, pH 6.8, 2% wt/vol SDS, 10% glycerol, 50 mM DTT, 0.01% wt/vol bromophenol blue). The cell lysates were sonicated for 10 s, centrifuged at 10,000 g for 10 min, and dissolved in 15% SDS by using ␤ -actin as a loading control. Mouse anti-COX2 antibody (1:1 dilution), anti -␤ -actin (1:2,000 dilution; Thermo Fisher Scientifi c) antibody, mouse anti -5-LO antibody (1:250 dilution; BD) and ovine anti -15-LO antibody (1:250 dilution; Cayman Chemical) were used to detect 5-LO and 15-LO. Rabbit anti-EP1, -EP2, -EP3, and -EP4 receptor antibodies (1:200; Cayman Chemical) were used to detect EP1, EP2, EP3, and EP4 receptor protein.
RT-PCR.
Total RNA was extracted as specifi ed in cells-to-cDNA II kit (Ambion). In brief, 5 × 10 5 mononuclear cells/ml/well in 12-well cluster plates were dislodged and lysed with 100 μ l of ice-cold cell lysis II buff er and then 2 μ l DNase I was added. Primer sequences used for COX2 were
